Page last updated: 2024-12-08

3,4-divanillyltetrahydrofuran

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

3,4-divanillyltetrahydrofuran: lignan with the highest binding affinity; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID182210
CHEMBL ID405043
SCHEMBL ID3470642
MeSH IDM0286681

Synonyms (15)

Synonym
CHEMBL405043
3,4-divanillyltetrahydrofuran
4-[[4-[(4-hydroxy-3-methoxyphenyl)methyl]oxolan-3-yl]methyl]-2-methoxyphenol
3,4-divanilyletrahydrofuran
creosol, alpha,alpha'-(tetrahydro-3,4-furandiyl)di-
34730-78-4
SCHEMBL3470642
(-) 3,4-divanillyl tetrahydrofuran
3,4-divanillyl tetrahydrofuran
ROGUIJKVZZROIQ-UHFFFAOYSA-N
Q4634070
4,4'-(tetrahydrofuran-3,4-diyldimethanediyl)bis(2-methoxyphenol)
scutellarein tetramethylether(rg)
DTXSID20956217
4,4'-dihydroxy-3,3'-dimethoxy-9,9'-epoxylignan

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
" To better understand its pharmacological activities, we need to determine its pharmacokinetic profiles."( Study on pharmacokinetics of 3,4-divanillyltetrahydrofuran in rats by ultra-fast liquid chromatography/tandem mass spectrometry.
Chai, C; Cui, XB; Shan, CX; Sun, X; Wang, XZ; Wen, HM; Yu, S, 2016
)
0.73

Bioavailability

ExcerptReferenceRelevance
" These findings indicate how nonsteroidal ligands of SHBG maybe designed to modulate the bioavailability of sex steroids."( Molecular interactions between sex hormone-binding globulin and nonsteroidal ligands that enhance androgen activity.
Das, S; Hammond, GL; Round, P; Van Petegem, F; Wähälä, K; Wu, TS, 2020
)
0.56
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (1)

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Sex hormone-binding globulinHomo sapiens (human)Kd0.30900.00020.34964.7863AID318680
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Molecular Functions (3)

Processvia Protein(s)Taxonomy
androgen bindingSex hormone-binding globulinHomo sapiens (human)
protein bindingSex hormone-binding globulinHomo sapiens (human)
steroid bindingSex hormone-binding globulinHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (2)

Processvia Protein(s)Taxonomy
extracellular regionSex hormone-binding globulinHomo sapiens (human)
extracellular exosomeSex hormone-binding globulinHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID318680Displacement of [3H]5alpha dihydrotestosterone from human sex hormone binding globulin2008Journal of medicinal chemistry, Apr-10, Volume: 51, Issue:7
An updated steroid benchmark set and its application in the discovery of novel nanomolar ligands of sex hormone-binding globulin.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's1 (20.00)29.6817
2010's1 (20.00)24.3611
2020's2 (40.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 35.33

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index35.33 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.86 (4.65)
Search Engine Demand Index39.83 (26.88)
Search Engine Supply Index1.91 (0.95)

This Compound (35.33)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]